The investigation of chronic fatigue syndrome: A case-study of the limitations of inductive inferences and non-falsifiable hypotheses in medical research

Medical Hypotheses

Volumn 60, Issue 5, 2003, Pages 760-766

  Hyams, Kenneth C ^a,b  

^a DEPARTMENT OF VETERANS AFFAIRS   (United States)

^b Veterans Administration Central Office   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; ANTIDEPRESSANT AGENT; HYDROCORTISONE; VITAMIN;

ANALYSIS; ANALYTICAL ERROR; ARTHRALGIA; ARTICLE; CASE STUDY; CHRONIC DISEASE; CHRONIC FATIGUE SYNDROME; CLINICAL OBSERVATION; DEPRESSION; DIGESTIVE SYSTEM FUNCTION DISORDER; DISEASE ASSOCIATION; ELECTRIC SHOCK; EMPIRICISM; EPSTEIN BARR VIRUS; EVALUATION; FATIGUE; FEVER; HUMAN; HYPOCHONDRIASIS; HYPOTHESIS; IRRITABILITY; LABORATORY TEST; LOGIC; MEDICAL RESEARCH; MEDICINE; MEMORY DISORDER; MENTAL CONCENTRATION; MENTAL DISEASE; MYALGIA; NERVOUS SYSTEM; NEURASTHENIA; PHILOSOPHY; PHYSICAL EXAMINATION; PREVALENCE; PRIORITY JOURNAL; SCIENTIFIC LITERATURE; SLEEP DISORDER; SYMPTOM; TREATMENT FAILURE; VALIDATION PROCESS; VIRUS INFECTION;

HUMAN HERPESVIRUS 4;

EID: 0037402949     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(03)00062-8     Document Type: Article

References (83)

1. Popper K. R. The Logic of Scientific Discovery. London: Routledge, 1997.
2. Popper K. R. Conjectures and Refutations: The Growth of Scientific Knowledge. London: Routledge, 1992.
3. Popper K. R. Realism and the Aim of Science. London: Routledge, 2000.
4. Popper K. R. In: The Logic of Scientific Discovery. London: Routledge, 1997: 32-33.
5. Popper K. R. In: The Logic of Scientific Discovery. London: Routledge, 1997: 33.
6. Popper K. R. In: Realism and the Aim of Science. London: Routledge, 2000: 36.
7. Maclure M. Inventing the AIDS virus hypothesis: an illustration of scientific vs unscientific induction. Epidemiology 1998; 9: 467-473.
8. Ng S. K. C. Does epidemiology need a new philosophy? A case study of logical inquiry in the acquired immunodeficiency syndrome epidemic. Am J Epidemiol 1991; 133: 1073-1077.
9. Weed D. L. An epidemiological application of Popper's method. J Epidemiol Community Health 1985; 39: 277-285.
10. Bunker H. A. Symposium on neurasthenia: from Beard to Freud. Med Rev Rev 1930; 36: 108-114.
11. Wessely S. Old wine in new bottles: neurasthenia and ME. Psychol Med 1990; 20: 35-53.
12. Straus S. E. History of chronic fatigue syndrome. Rev Infect Dis 1991; 13(suppl 1): S2-S7.
13. Beard G. Neurasthenia, or nervous exhaustion. The Boston Medical and Surgical Journal 1869; 3: 217-220.
14. Beard G. M. A Practical Treatise on Nervous Exhaustion [Neurasthenia): Its Symptoms, Nature, Sequences, Treatment. New York: William Wood, 1880.
15. Beard G. M. American Nervousness: Its Causes and Consequences. New York: GP Putnam's Sons, 1881.
16. Clark A. Some observations concerning what is called neurasthenia. Lancet 1886; 1: 1-2.
17. Lane C. The mental element in the etiology of neurasthenia. J Nerv Ment Dis 1906; 33: 463-466.
18. Wechsler I. S. Is neurasthenia an organic disease? Med Rev Rev 1930; 36: 115-121.
19. Barnes D. M. Mystery disease at Lake Tahoe challenges virologists and clinicians. Science 1986; 234: 541-542.
20. Johnson H. Osler's Web: Inside the Labyrinth of the Chronic Fatigue Syndrome Epidemic. New York: Crown Publishers, 1996.
21. Holmes G. P., Kaplan J. E., Gantz N. M. et al. Chronic fatigue syndrome: a working case definition. Ann Intern Med 1988; 108: 387-389.
22. Lloyd A. R., Hickie I., Boughton C. R., Spencer O., Wakefield D. Prevalence of chronic fatigue in an Australian population. Med J Aust 1990; 153: 522-528.
23. Sharpe M. C., Archard L. C., Banatvala J. E. et al. A report - chronic fatigue syndrome: guidelines for research. J R Soc Med 1991; 84: 118-121.
24. Fukuda K., Straus S. E., Hickie I., Sharpe M. C., Dobbins J. G., Komaroff A., The International Chronic Fatigue Syndrome Study Group. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Intern Med 1994; 121: 953-959.
25. Rosenberg C. E. The place of George M. Beard in nineteenth-century psychiatry. Bull Hist Med 1962; 36: 245-259.
26. Greenberg D. B. Neurasthenia in the 1980s: chronic mononucleosis, chronic fatigue syndrome, and anxiety and depressive disorders. Psychosomatics 1990; 31: 129-137.
27. Muscio B. Is a fatigue test possible? Br J Psychol 1921: 31-46.
28. Forbes W. H. Problems arising in the study of fatigue. Psychosom Med 1943; 5: 155-157.
29. Hyams K. C., Wignall F. S., Roswell R. War syndromes and their evaluation: from the US Civil War to the Persian Gulf War. Ann Intern Med 1996; 125: 398-405.
30. Lewis T. The Soldier's Heart and the Effort Syndrome. New York: PB Hoeber, 1919.
31. Wood P. Aetiology of Da Costa's syndrome. BMJ 1941; 1: 845-851.
32. DuDois R. E., Seeley J. K., Brus I. et al. Chronic mononucleosis syndrome. South Med J 1984; 77: 1376-1382.
33. Jones J. F., Ray C. G., Minnich L. L., Hicks M. J., Kibler R., Lucas D. O. Evidence for active Epstein-Barr virus infection in patients with persistent, unexplained illnesses: elevated anti-early antigen antibodies. Ann Intern Med 1985; 102: 1-7.
34. Straus S. E., Tosato G., Armstrong G. et al. Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection. Ann Intern Med 1985; 102: 7-16.
35. Horwitz C. A., Henle W., Henle G., Rudnick H., Latts E. Long-term serological follow-up of patients for Epstein-Barr virus after recovery from infectious mononucleosis. J Infect Dis 1985; 151: 1150-1153.
36. Holmes G. P., Kaplan J. E., Stewart J. A., Hunt B., Pinsky P. F., Schonberger L. B. A cluster of patients with a chronic mononucleosislike syndrome: is Epstein Barr virus the cause? JAMA 1987; 257: 2297-2302.
37. Gold D., Bowden R., Sixbey J. et al. Chronic fatigue: a prospective clinical and virologic study. JAMA 1990; 264: 48-53.
38. Mawle A. C., Nisenbaum R., Dobbins J. G. et al. Seroepidemiology of chronic fatigue syndrome: a case-control study. Clin Infect Dis 1995; 21: 1386-1389.
39. Straus S. E., Dale J. K., Tobi M. et al. Acyclovir treatment of the chronic fatigue syndrome: lack of efficacy in a placebo-controlled trial. N Engl J Med 1988; 319: 1692-1698.
40. Straus S. E. The chronic mononucleosis syndrome. J Infect Dis 1988; 157: 405-412.
41. Carver L. A., Flanigan S. J., Connallon P. F., Crossley-Miller M. K. Epstein-Barr virus infection in Desert Storm reservists. Mil Med 1994; 159: 580-582.
42. Milner I. B., Axelrod B. N., Pasquantonio J., Sillanpaa M. Is there a Gulf war syndrome? JAMA 1994; 271: 661.
43. Natelson B. H., Ye N., Moul D. E. et al. High titers of anti-Epstein-Barr virus DNA polymerase are found in patients with severe fatiguing illness. J Med Virol 1994; 42: 42-46.
44. Lane T. J., Matthews D. A., Manu P. The low yield of physical examinations and laboratory investigations of patients with chronic fatigue. Am J Med Sci 1990; 299: 313-318.
45. Komaroff A. L., Buchwald D. Symptoms and signs of chronic fatigue syndrome. Rev Infect Dis 1991; 13(suppl 1): S8-S11.
46. Komaroff A. L. A 56-year-old woman with chronic fatigue syndrome. JAMA 1997; 278: 1179-1185.
47. Joyce J., Hotopf M., Wessely S. The prognosis of chronic fatigue and chronic fatigue syndrome: a systematic review. Q J Med 1997; 90: 223-233.
48. Mawle A. C., Reyes M., Schmid D. S. Is chronic fatigue syndrome an infectious diseases. Infect Agents Dis 1994; 2: 333-341.
49. Kroenke K., Wood D. R., Mangelsdorff A. D., Meier N. J., Powell J. B. Chronic fatigue in primary care: prevalence, patient characteristics, and outcome. JAMA 1988; 260: 929-934.
50. Abbey S. E., Garfinkel P. E. Chronic fatigue syndrome and depression: cause, effect or covariate. Rev Infect Dis 1991; 13(suppl 1): S73-S83.
51. Wessely S., Hotopf M., Sharpe M. Chronic Fatigue and its Syndromes. New York: Oxford University Press, 1998.
52. Buchwald D., Komaroff A. L. Review of laboratory findings for patients with chronic fatigue syndrome. Rev Infect Dis 1991; 13(suppl 1): S12-S18.
53. Manu P., Lane T. J., Matthews D. A. The pathophysiology of chronic fatigue syndrome: confirmations, contradictions, and conjectures. Int J Psychiatry Med 1992; 22: 397-408.
54. Hickie I., Lloyd A., Hadzi-Pavlovic D., Parker G., Bird K., Wakefield D. Can the chronic fatigue syndrome be defined by distinct clinical features? Psychol Med 1995; 25: 925-935.
55. Moss-Morris R., Petrie K. J., Large R. G., Kydd R. R. Neuropsychological deficits in chronic fatigue syndrome: artifact or reality? J Neurol Neurosurg Psychiatry 1996; 60: 474-477.
56. Leese G., Chattington P., Fraser W., Vora J., Edwards R., Williams G. Short-term night-shift working mimics the pituitary-adrenocortical dysfunction in chronic fatigue syndrome. J Clin Endocrinol Metab 1996; 81: 1867-1870.
57. Freeman R., Komaroff A. L. Does the chronic fatigue syndrome involve the autonomic nervous system? Am J Med 1997; 102: 357-364.
58. Whiting P., Bagnall A.-M., Sowden A. J., Cornell J. E., Mulrow C. D., Ramirez G. Interventions for the treatment and management of chronic fatigue syndrome. JAMA 2001; 286: 1360-1368.
59. Price R. K., North C. S., Wessely S., Fraser V. J. Estimating the prevalence of chronic fatigue syndrome and associated symptoms in the community. Public Health Rep 1992; 107: 514-522.
60. Gunn W. J., Connell D. B., Randall B. In: Epidemiology of Chronic Fatigue Syndrome: The Centers for Disease Control study Ciba Foundation Symposium 173. Chichester, England: Wiley, 1993: 83-101.
61. Buchwald D., Umali P., Umali J., Kith P., Pearlman T., Komaroff A. L. Chronic fatigue and the chronic fatigue syndrome: prevalence in a Pacific Northwest health care system. Ann Intern Med 1995; 123: 81-88.
62. Reyes M., Gary H. E., Dobbins J. G. et al. Surveillance for chronic fatigue syndrome - four US cities, September 1989 through August 1993. MMWR CDC Surveillance Summaries 1997; 46: 1-13.
63. Wessely S., Chalder T., Hirsch S., Wallace P., Wright D. The prevalence and morbidity of chronic fatigue and chronic fatigue syndrome: a prospective primary care study. Am J Public Health 1997; 87: 1449-1455.
64. Nisenbaum R., Reyes M., Mawle A. C., Reeves W. C. Factor analysis of unexplained severe fatigue and interrelated symptoms: overlap with criteria for chronic fatigue syndrome. Am J Epidemiol 1998; 148: 72-77.
65. Jason L. A., Taylor R. R., Kennedy C. L. et al. A factor analysis of chronic fatigue symptoms in a community-based sample. Soc Psychiatry Psychiatr Epidemiol 2002; 37: 183-189.
66. Bourdette D. N., McCauley L. A., Barkhuizen A. et al. Symptom factor analysis, clinical findings, and functional status in a population-based case control study of Gulf War unexplained illness. J Occup Environ Med 2001; 43: 1026-1040.
67. Richman J. A., Flaherty J. A., Rospenda K. M. Chronic fatigue syndrome: Have flawed assumptions been derived from treatment-based studies. Am J Public Health 1994; 84: 282-284.
68. Wessely S., Chalder T., Hirsch S., Pawlikowska T., Wallace P., Wright D. J. M. Postinfectious fatigue: prospective cohort study in primary care. Lancet 1995; 345: 1333-1338.
69. Nimnuan C., Hotopf M., Wessely S. Medically unexplained symptoms: an epidemiological study in seven specialities. J Psychosom Res 2001; 51: 361-367.
70. Hyams K. C. Developing case definitions for symptom-based conditions: the problem of specificity. Epidemiol Rev 1998; 20: 148-156.
71. Wessely S., Powell R. Fatigue syndromes: a comparison of chronic 'postviral' fatigue with neuromuscular and affective disorders. J Neurol Neurosurg Psychiatry 1989; 52: 940-948.
72. Wessely S. Chronic fatigue syndrome: a 20th century illness. Scand J Work Environ Health 1997; 23(suppl 3): 17-34.
73. Popper K. R. In: The Logic of Scientific Discovery. London: Routledge, 1997: 46.
74. Streeten D. H. P. The nature of chronic fatigue. JAMA 1998; 280: 1094-1095.
75. Holmes G. P. Defining the chronic fatigue syndrome. Rev Infect Dis 1991; 13(suppl 1): S53-S55.
76. Natelson B. H., Johnson S. K., DeLuca J. et al. Reducing heterogeneity in chronic fatigue syndrome: a comparison with depression and multiple sclerosis. Clin Infect Dis 1995; 21: 1202-1210.
77. Wilson A., Hickie I., Hadzi-Pavlovic D. et al. What is chronic fatigue syndrome? Heterogeneity within an international multicentre study. Aust N Z J Psychiatry 2001; 35: 520-527.
78. Buchwald D., Ashley R. L., Pearlman T., Kith P., Komaroff A. L. Viral serologies in patients with chronic fatigue and chronic fatigue syndrome. J Med Virol 1996; 50: 25-30.
79. Buchwald D., Umali J., Pearlman T., Kith P., Ashley R., Wener M. Postinfectious chronic fatigue: A distinct syndrome. Clin Infect Dis 1996; 23: 385-387.
80. Maclure M. Demonstration of deductive meta-analysis: ethanol intake and risk of myocardial infarction. Epidemiol Rev 1993; 15: 328-351.
81. Margolin A., Avants S. K., Kleber H. D. Investigating alternative medicine therapies in randomized controlled trials. JAMA 1998; 280: 1626-1628.
82. Senn S. J. Falsificationism and clinical trials. Stat Med 1991; 10: 1679-1692.
83. Maclure M. Karl Popper and his unending quest: an epidemiologic interpretation. Epidemiology 1995; 6: 331-334.